← Archive

All Policy, No Payment: The Maternal Health Reimbursement Infrastructure Gap That the Momnibus Won't Fix

The coverage narrative is real. The payment narrative is not keeping pace. And the gap between them is what operators and investors are most consistently underweighting.

Pediatric Health Dispatch — Deep Dispatch | June 12, 2026

What the Policy Record Actually Shows

The maternal health policy surge this spring is real. On May 14, Sen. Kirsten Gillibrand and Rep. Brian Fitzpatrick led the bipartisan reintroduction of the Moms Matter Act, directing grant funding toward community-based maternal mental health programs and workforce expansion. The Fitzpatrick co-sponsorship matters: a Republican signing onto Momnibus legislation in this Congress signals more than symbolic support for a specific workforce provision. Five days later, Rep. Lucy McBath and Sen. Elizabeth Warren led more than 70 lawmakers in reintroducing the Maternal Health Pandemic Response Act, strengthening data collection and emergency-care infrastructure for pregnant and postpartum patients.

The policy activity extends beyond Capitol Hill. CMS's updated EPSDT Coverage Guide, released in May, clarified that states cannot impose hard utilization limits on medically necessary behavioral health or telehealth services for children and postpartum patients. The fourth annual Maternal Mental Health State Report Cards showed the U.S. moving from a C- to a C overall, with ten states earning Bs for the first time. The new Parental Support domain, added this year to score states on paid leave and affordable childcare access, earned the U.S. an effective F: 31 of 50 states scored under one star. That score is significant not because it is surprising but because it formally widens the maternal mental health frame from clinical treatment to family economic supports, the direction where state Medicaid and employer-benefit demand is likely to migrate over the next five years.

Underlying all of it is the Transforming Maternal Health model, the CMS Innovation Center's ten-year initiative running through 2034. Four states are now active participants: California focused on midwifery access and SDoH screening in the Central Valley, Minnesota on oral health expansion, doula coverage, and home monitoring, New York on RPM for hypertensive disorders, and Arkansas on rural health clinic access and C-section reduction. Each participating state can receive up to $17 million in cooperative agreement funding to build data infrastructure, train providers, and expand care teams.

The coverage narrative is substantively real. Black women die from pregnancy-related causes at roughly three times the rate of white women. These deaths are disproportionately preventable. The legislative and regulatory activity reflects years of evidence-based advocacy. But the coverage narrative and the payment narrative are running at materially different speeds, and that gap is what operators and investors are most consistently underweighting.

Where the Payment Infrastructure Falls Apart

The structural problem is that multiple payment mechanisms are contracting at precisely the same moment that coverage obligations are expanding.

Start with what the TMaH model actually pays for. The $17 million per state is not clinical care reimbursement. It funds infrastructure: data integration, provider training, the administrative cost of expanding care teams to include doulas and midwives. The model shifts to "Provider Infrastructure Payments" beginning in year three, then to upside-only quality and performance incentives from year four onward. A maternal health startup operating in a TMaH state cannot count on the model itself for recurring clinical revenue before at least 2028. That revenue still has to come from Medicaid managed care contracts, RPM billing codes, and commercial payers. TMaH creates the policy conditions and some of the data infrastructure for better reimbursement. It does not replace the reimbursement infrastructure companies need to survive long enough to reach the performance-incentive phase.

Those channels are under their own pressure. In California, CalAIM's Enhanced Care Management benefit represents the most ambitious state-level attempt to integrate SDoH and maternal care coordination into Medicaid managed care. Member enrollment grew 250% in the first two years of the benefit. Provider enrollment grew 59%. The gap between those two numbers points at a provider network that is undersized for the population it is meant to serve, and the financial picture underneath it explains why: a significant portion of providers serving California Children's Services beneficiaries and postpartum patients report that current ECM payment rates do not cover their administrative and clinical costs, with roughly 20% running the program at a loss. That is not a temporary scaling problem. It reflects the fundamental difficulty of sustaining whole-person care coordination at Medicaid managed care rates before outcomes data justify higher VBP-linked payments.

The CMS directed-payments cap, which PHD analyzed last week in the context of children's hospitals and provider-sponsored pediatric plans, has an equally significant maternal health dimension that the headline coverage largely missed. Georgetown's Center for Children and Families was explicit: the rule's fallback benchmark mechanism specifically exposes maternal, behavioral health, and home-and-community-based services. When a service lacks a usable total published Medicare payment rate (a routine situation for prenatal, postpartum, and perinatal psychiatric services that Medicare does not routinely cover for its core adult-over-65 population), the proposed rule falls back to the Medicaid state plan rate rather than a maternal-adjusted benchmark. For maternal health companies and health systems that depend on SDP-enhanced Medicaid rates flowing through managed care contracts, the cap creates a ceiling that was not part of their financial models when those contracts were written.

The federal budget proposals add a third pressure point. The administration's proposed FY2026 budget would eliminate Title X family planning funding, the Healthy Start program, and the CDC Safe Motherhood and Infant Health Portfolio. These are not enacted cuts, and Healthy Start and Title X both have bipartisan congressional defenders. But as a stated policy direction, the proposals signal that the public-health infrastructure layer that functions as the front door for high-risk Medicaid families — prenatal access, community referral networks, the trust relationships that lower-acuity digital tools depend on for engagement — is not a protected budget category in the current administration. Maternal health startups serving Medicaid populations cannot build acquisition assumptions on that infrastructure remaining intact.

Coverage expansion and payment contraction are not contradictory from a federal accounting standpoint. For a maternal health company with a multi-year operating plan, they compound.

What Survives

The companies positioned to move through this environment are not the ones with the best clinical programs or the most favorable policy mentions. They are the ones that designed for payment fragility from the beginning.

Maven Clinic is the clearest example of durable architecture in this market. Maven's $1.7 billion valuation reflects a business model explicitly insulated from Medicaid reimbursement variability: its 2,300+ enterprise clients are self-insured employers and commercial health plans whose ROI calculus centers on NICU avoidance (each prevented NICU stay can eliminate more than $100,000 in self-insured claims), C-section reduction, and workforce retention. Maven reports a 27% reduction in NICU stays and a 94% return-to-work rate for new parents on its platform. Those are employer-grade outcomes metrics, not clinical-grade ones, and that distinction matters. A benefits director at a large employer is not evaluating maternal health platforms on EPSDT compliance. Maven's commercial channel survives Medicaid reimbursement compression because it was never structurally dependent on it.

The more strategically interesting position belongs to companies building toward multi-channel architecture rather than already holding it. Babyscripts has operated with more than 70% Medicaid users since at least 2021, but its infrastructure model — it sells to OB practices, health systems, payers, and public-health programs rather than operating a branded clinical front door — creates a specific advantage in the TMaH environment. TMaH's Phase 3 performance incentives explicitly tie payment to RPM for hypertension and depression screening, the exact care-management infrastructure Babyscripts delivers. A company with documented Medicaid RPM outcomes, operating inside a TMaH state's infrastructure investment phase, has a credible path to both VBP-linked payment protections and TMaH performance payments when the incentive phase begins. The infrastructure bet requires surviving the payment-constrained phase first, which is where the multi-channel question becomes existential rather than strategic.

Pomelo Care, expanding beyond its original maternity navigation wedge into broader maternal-infant care infrastructure, is building toward a similar hybrid position. Its movement toward outcomes documentation and payer contracting suggests a deliberate strategy for the environment PHD is describing: use the navigation relationship as an enrollment channel, build clinical outcomes data, and convert that data into defensible VBP-linked payment structures before the baseline rate environment gets tighter.

The companies most exposed are those built on single-channel assumptions that seemed reasonable two years ago. Pure Medicaid maternal health platforms without a commercial anchor are underwriting a multi-year operating plan on policy signals that have historically translated slowly, if at all, into payment reality. Community-based maternal health models that were built to Title X referral infrastructure face a distribution problem if those programs are reduced or restructured. Doula-coordination platforms that assumed rapid 50-state Medicaid doula coverage expansion are running into the same provider-economics problem CalAIM ECM surfaced: states have adopted the benefit in principle before solving the rate problem that makes it sustainable for providers.

The strategic read for operators and investors in 2026: use the TMaH policy window (years one through three, through 2027 to 2028) to build outcomes data in the states where CMS is actively measuring. Use the Momnibus directional signals to pre-position for the grant programs that any surviving component would fund, particularly the Moms Matter Act's workforce provision, which has the clearest bipartisan path. And anchor commercial viability in the employer channel, where the NICU avoidance and return-to-work ROI math works today, not in Medicaid rate stability that the current policy record no longer supports treating as a baseline assumption.

The companies that exit well in this market will not be the ones that waited for the policy floor to rise. They will be the ones that built around the possibility it would not.

---

---